Hematologic germline testing revealed heterozygosity for the pathogenic BRCA1 p.Lys918Serf∗82 variant and pathogenic PMS2 p.Cys843Tyr variant, consistent with hereditary breast and ovarian cancer syndrome and Lynch syndromes, respectively (Table II). This evidence concerns the gene PMS2 and Lynch syndrome.